−0.4840USD
−6.35 MUSD
5.15 KUSD
54.96 M
About Heart Test Laboratories, Inc.
Sector
Industry
CEO
Andrew Christopher Simpson
Website
Headquarters
Southlake
Employees (FY)
12
Founded
2008
FIGI
BBG0185L0044
Heart Test Laboratories, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded in 2008 and is headquartered in Southlake, TX.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HSCS is 0.0999 USD — it has decreased by 0.20% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Heart Test Laboratories, Inc. stocks are traded under the ticker HSCS.
Heart Test Laboratories, Inc. is going to release the next earnings report on Jul 17, 2024. Keep track of upcoming events with our Earnings Calendar.
HSCS stock is 3.98% volatile and has beta coefficient of 1.37. Check out the list of the most volatile stocks — is Heart Test Laboratories, Inc. there?
HSCS earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.12 USD resulting in a −33.33% surprise. The estimated earnings for the next quarter are −0.06 USD per share. See more details about Heart Test Laboratories, Inc. earnings.
Yes, you can track Heart Test Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
HSCS stock has fallen by 7.67% compared to the previous week, the month change is a 16.75% fall, over the last year Heart Test Laboratories, Inc. has showed a 90.92% decrease.
HSCS net income for the last quarter is −1.64 M USD, while the quarter before that showed −1.75 M USD of net income which accounts for 5.98% change. Track more Heart Test Laboratories, Inc. financial stats to get the full picture.
No, HSCS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HSCS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Heart Test Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 12.00 employees. See our rating of the largest employees — is Heart Test Laboratories, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Heart Test Laboratories, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Heart Test Laboratories, Inc. stock shows the sell signal. See more of Heart Test Laboratories, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Heart Test Laboratories, Inc. future price: according to them, HSCS price has a max estimate of 1.00 USD and a min estimate of 0.35 USD. Read a more detailed Heart Test Laboratories, Inc. forecast: see what analysts think of Heart Test Laboratories, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Heart Test Laboratories, Inc. EBITDA is −6.00 M USD, and current EBITDA margin is −118.18 K%. See more stats in Heart Test Laboratories, Inc. financial statements.